Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 3Recruiting 2Completed 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Specimen Handling 60Magnetic Resonance Spectroscopy 41Carboplatin 32Gemcitabine 29Cyclophosphamide 29Cisplatin 25Biopsy 25Bevacizumab 24pembrolizumab 23Radiotherapy 22Paclitaxel 22Standard of Care 21Injections 21Drug Therapy 21Capecitabine 21fludarabine 20Oxaliplatin 20venetoclax 19Nivolumab 18toripalimab 17Interviews as Topic 17Dexamethasone 16Blood Specimen Collection 16tislelizumab 14Radiosurgery 14cemiplimab 13anlotinib 13Azacitidine 13Pemetrexed 12Irinotecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × CP protocol × 90 days × Clear all
NCT07610525 2026-05-28

Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial

M.D. Anderson Cancer Center

Phase 2 Not yet recruiting
200 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡